15.2 DLCO & Exercise Test Reliability
Key Takeaways
DLCO reliability (III.B.5) hinges on inspired volume vs VC, breath-hold quality/timing, alveolar sample integrity, and recognition of COHb and related confounders.
A mathematically complete DLCO printout is unreliable if VI/VC is inadequate, BHT is wrong, or the sample is contaminated by dead-space or leak.
Exercise and field-walk reliability (III.B.6–7) requires protocol adherence, valid SpO2 (motion/perfusion), measured course distance, and appropriate practice walks.
Home testing (III.B.8) expands access but weakens unsupervised effort, environment, and device-quality controls—report and interpret with those limits explicit.
When DLCO or walk metrics are technically compromised, retest or qualify the report; do not treat artifact as diffusion defect or true exertional desaturation.
DLCO Reliability Is More Than a Green Checkmark
After Domain II acceptability for single-breath DLCO, III.B.5 asks whether the reported diffusing capacity is reliable enough for clinical use. CO uptake numbers are sensitive to inspired volume, breath-hold timing, gas sample purity, and blood CO/hemoglobin state. An RPFT who only glances at “DLCO % predicted” without those checks will mislabel technical failure as interstitial disease—or miss a real diffusion defect hidden under a short breath-hold.
Core DLCO Reliability Checks
Inspired volume relative to VC (VI/VC)
The patient must inspire a large fraction of vital capacity so alveolar volume and CO distribution represent the lung being tested.
| VI/VC situation | Reliability implication | Typical action |
|---|---|---|
| VI clearly adequate vs concurrent VC | Supports usable VA/DLCO | Proceed if other criteria met |
| VI substantially below expected VC fraction | Under-inspiration; DLCO/VA may be biased | Recoach full inspiration; repeat |
| VC itself unreliable (incomplete spirometry) | VI/VC ratio loses meaning | Fix spirometry effort first |
| Leak during inspiration | Inspired volume false | Reject trial |
Exam stems often pair a “low DLCO” with a tracing showing small inspired volume and weak effort—reliability answer is retest, not pulmonary fibrosis narrative.
Breath-hold time (BHT)
BHT must match the method’s timing definition (ATS/ERS-aligned start/end rules used by the instrument and SOP). Too short or too long, or an unsteady hold with Valsalva/Müller straining, undermines the single-breath model.
Unreliable BHT patterns:
- Patient exhales early or inhales during “hold”
- Glottic leak (CO/tracer continuum unstable)
- Extreme pressures (strain) altering pulmonary blood volume
- Software BHT outside acceptable window with no override justification
Alveolar sample quality
DLCO depends on analyzing alveolar gas, not dead-space–heavy early gas or room-air contamination.
| Sample problem | Effect | Reliability response |
|---|---|---|
| Inadequate washout volume before sample | Dead-space contamination → erroneous FA_CO/FA_tracer | Reject; adjust discard/sample volumes per standards/SOP |
| Leak at mouthpiece during hold/exhalation | Tracer/CO dilution errors | Reject; reseat; repeat |
| Analyzer lag/mis-timing | Wrong portion of exhalate | Service/method check; do not average bad samples |
| Water/CO2 handling faults | Biased analyzer readings | Equipment QC path |
COHb and related confounders
Carboxyhemoglobin from smoking or CO exposure occupies Hb binding sites and alters measured DLCO. Reliability judgment includes:
- Documented smoking/vaping timing relative to test
- Measured COHb (when available) and appropriate correction/reporting practice per lab standards
- Anemia/polycythemia (Hb) affecting CO uptake—often corrected in reporting but still part of reliability/context
- Recent supplemental O2 affecting comparison to room-air reference conditions
A low DLCO in a patient who smoked immediately before testing is not automatically ILD until COHb and maneuver quality are addressed. Conversely, normal-looking DLCO with high COHb may still be clinically misleading without correction notes.
Replicate agreement
Within-session DLCO trials should cluster. Large scatter after several attempts means low reliability even if one value looks “pretty.” Prefer standards-aligned averaging rules only among acceptable trials.
Exercise & Field-Walk Reliability (III.B.6–7)
Exercise and walking tests produce distance, symptoms, SpO2, heart rate, and sometimes BP/ECG. Reliability fails when the protocol or sensors fail—even if the patient “tried hard.”
Protocol adherence
| Element | Unreliable if… | Why it matters |
|---|---|---|
| Timing (e.g., 6 minutes) | Clock wrong; early stop undocumented | Distance not comparable |
| Instructions / encouragement | Inconsistent scripting | Effort and distance shift |
| Supplemental O2 policy | FiO2 changes mid-walk without plan | SpO2/distance uninterpretable vs prior |
| Workload steps (CPET/treadmill) | Stage skips, speed errors | Metabolic comparisons invalid |
| Stop criteria | Continue through unsafe symptoms or stop without reason codes | Safety + data integrity |
Oximeter reliability (motion & perfusion)
Pulse oximeters during walking are vulnerable to motion artifact, poor perfusion, ambient light, and probe placement.
Suspect SpO2 unreliability when:
- Pulse rate from oximeter disagrees with ECG/palpated rate
- SpO2 jumps erratically without physiologic pattern
- Cold fingers, nail coatings, or probe repeatedly reseated mid-test
- Patient clenches probe hand on walker/treadmill rail
Reliable practice: optimize probe site before start, confirm pulse agreement, treat wild SpO2 swings as artifact until proven, and document signal quality. Do not report a dramatic “desaturation” from a single motion-glitch nadir without waveform/pulse corroboration.
Practice walks and learning effect
A first 6MWT often underestimates true distance because of unfamiliarity. Standards commonly support a practice consideration or standardized repeat strategy. Reliability of “best distance” depends on whether the lab’s protocol for practice/repeat was followed and documented. Comparing today’s first-ever walk to last year’s third walk without noting learning effect is a reliability trap.
Course measurement errors
Distance is only as good as the course.
| Error | Effect |
|---|---|
| Unmeasured or guessed corridor length | Systematic bias in meters/feet |
| Turns counted inconsistently | Random error, poor serial comparison |
| Different course than prior visit | False improvement/decline |
| Obstacles / busy hallway stops | Nonphysiologic distance limits |
Exam answer when distance “falls 80 m” but the lab moved from a 30 m to an unmarked short hallway: question reliability of the comparison before declaring clinical worsening.
Home Testing Reliability Limitations (III.B.8)
Home spirometry and related remote testing improve access and serial sampling frequency, but reliability is constrained:
- Unsupervised effort — no real-time flow-volume coaching by an RPFT
- Device quality & calibration state — consumer/home sensors may lack full lab QC
- Environment — posture, nose clip use, distractions, illness day effects
- Maneuver selection — software may auto-pick peaks the patient cannot validate
- Context gaps — medication timing, smoking, recent exercise often incomplete
Reliability posture for the exam: Home data can trend and screen, but discordant or decision-critical values usually need laboratory confirmation. Reports should state unsupervised limitations rather than treat home FEV1 as identical in authority to a standards-aligned lab session.
Integrated Exam Scenarios
DLCO scenario: VI is 55% of measured VC, BHT short with leak flags, patient smoked 20 minutes prior, DLCO 45% predicted. Reliability: Do not lock in severe diffusion defect; correct process (inspiration, hold, COHb/timing) and retest.
Walk scenario: 6MWT SpO2 falls to 82% for two seconds while oximeter HR is 40 bpm and ECG shows 118 bpm; distance protocol correct. Reliability: SpO2 nadir is motion/perfusion artifact until a stable probe agrees with pulse; do not treat 82% as proven desaturation.
Home scenario: Home FEV1 drops 400 mL overnight; lab spirometry next day is repeatable and near baseline with good peaks. Reliability: Weight the supervised session higher; investigate home effort/device factors.
Workflow Checklist (III.B.5–8)
- DLCO: VI/VC → BHT → sample/leak → replicate agreement → COHb/Hb/O2 context.
- Exercise/walk: protocol clock & coaching → course length → practice-walk policy → SpO2 pulse agreement → symptom scores documented.
- Home: label limitations; confirm critical decisions in lab when stakes are high.
- If any pillar fails: retest or qualify—never silently convert technical failure into a disease label.
Mastering these reliability gates is what Domain III.B scores: not recalling the DLCO formula alone, but knowing when the formula’s inputs were never trustworthy.
Which combination most clearly makes a low single-breath DLCO unreliable pending retest?
Adequate VI/VC, stable BHT in range, clean alveolar sample, nonsmoker, tight replicates
Normal Hb, practice 6MWT completed yesterday, home spirometer available
Inspired volume far below expected VC fraction, short/unstable breath-hold with leak flags, recent smoking without COHb context
TLC slightly above LLN on a separate body-box visit last year
During a 6-minute walk, SpO2 briefly reads 80% while the oximeter pulse rate is 48 bpm and simultaneous ECG heart rate is 120 bpm. What is the best reliability action?
Treat 80% as confirmed severe desaturation and stop documenting further SpO2
Suspect motion/perfusion artifact because pulse agreement failed; optimize probe and require corroborated readings before calling true desaturation
Average 80% with the pre-walk SpO2 to create a session mean for the report
Convert the walk to DLCO because oximetry is always more reliable than ECG
A lab compares this year’s 6MWT distance to last year’s but used a different, unmarked hallway without measuring path length. What is the main reliability problem?
COHb always rises during walking and invalidates distance
VI/VC ratio was not calculated during the walk
Practice walks are forbidden by all standards in every lab
Course measurement error systematically biases distance and undermines serial comparison
How should RPFT-level reliability thinking treat unsupervised home spirometry versus laboratory spirometry for a high-stakes clinical decision?
Home data may trend/screen but discordant or decision-critical results generally need supervised lab confirmation with explicit limitation language on home tests
Home and lab values are always interchangeable if the brand logo matches
Home testing is more reliable because patients are more relaxed
Any home FEV1 automatically overrides lab results from the same week
Sections you finish are checked off in the contents.